Skip navigation

Energizer buys feminine hygiene brands for $185M

Battery and consumer products maker Energizer Holdings Inc. says it is buying feminine care brands including Stayfree, Carefree and o.b. from Johnson & Johnson for $185 million in cash. Full story

Johnson & Johnson agrees to pay $22.9 million to end recall lawsuit

NEW YORK (Reuters) - Johnson & Johnson <JNJ.N> has agreed to pay $22.9 million to end a lawsuit from investors who claimed the company concealed quality-control failures that culminated in a broad recall of children's medicines, according to court filings. Full story

Johnson & Johnson slips from all-time highs

Johnson & Johnson shares edged lower Wednesday after analysts said the company's second-quarter results were solid but added that the health care giant's stock is trading at a fair price. Full story

J&J Consumer health head Sandra Peterson

During a conference call Tuesday to review Johnson & Johnson's second-quarter results, analysts asked about ongoing work to fix manufacturing deficiencies in the consumer health business that have resulted in most of the four dozen product recalls by the company since September 2009. Full story

News Summary: J&J 2Q net, sales up but issues loom

STRONG RESULTS: Johnson & Johnson's second-quarter net income more than doubled. Its adjusted net income jumped 18 percent to $4.29 billion, or $1.48 per share. Revenue was $17.88 billion, up 8.5 percent. Both topped analysts' expectations. Full story

Earnings roundup: Goldman Sachs, Johnson & Johnson

Among the earnings stories for Tuesday, July 16, from AP Business News: Full story

Sponsored Links

Articles

Johnson & Johnson results beat forecasts; Elan share sale helps

J&J 2Q profit jumps on higher sales, lower charges

Earnings Preview: J&J reports 2Q results Tuesday

Pharmacyclics, J&J file for cancer drug approval

Chevron vs. Johnson & Johnson: Which Dow Stock's Dividend Dominates?

Johnson & Johnson to buy Aragon for up to $1 billion

Johnson & Johnson recalls Cilest birth control pills

FDA approves Johnson & Johnson diabetes drug, canagliflozin

Jury awards $3.35 million in vaginal mesh case against Johnson & Johnson

Johnson & Johnson says its marketing practices being investigated

Video

  Money & medicine market

Johnson & Johnson and JMP are each up more than 25 percent this year. Should you buy stocks you know? CNBC's Jim Cramer and Herb Greenberg discuss.

  Earnings Squad: KO, GS, JNJ & YHOO

CNBC's Melissa Lee, Herb Greenberg and Kayla Tausche dissect the numbers on Coca-Cola's disappointing quarter, Goldman Sach's big beat, Johnson & Johnson's new record high, and Yahoo! after the bell.

  Tuesday's market roadmap

The "Squawk on the Street" news team reports on today's top business headlines, including this morning's earnings result for Goldman Sachs, Coca-Cola and Johnson & Johnson.

  Cramer's stocks to watch: JNJ, KO & GS

Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today Cramer provides his take on Johnson & Johnson, Goldman Sachs and Coca-Cola's earnings.

  Dow components report: JNJ & KO

A look at what's driving earnings at Coca-Cola and Johnson & Johnson, with Tom Anderson, Boston Private Bank.

advertisement | ad info

Related Photos

File of products made by Johnson & Johnson for sale on a store shelf in Westminster
File of products made by Johnson & Johnson for sale on a store shelf in Westminster

Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009 file photo. Johnson & Johnson reported higher-than-expected second quarter earnings as strong sales of prescription drugs and medical devises more than offset anemic growth of its consumer pr

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster
A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking

File photo of products made by Johnson & Johnson for sale on a store shelf in Westminster
File photo of products made by Johnson & Johnson for sale on a store shelf in Westminster

Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had be